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The subcellular localization of rap proteins in resting human neutrophils was investigated by immunoblot analysis with specific anti-rap2 and 
anti-rapl antibodies of the membrane proteins obtained from distinct subcellular fractions. Rap2 protein was mainly located in gelatinase- 
containing ranules, whereas rapl protein was detected both in gelatinase-containing granules and in fractions enriched in plasma membrane. 
Neither apl nor rap2 proteins were found in the cytosol or in azurophilic granules. Rap2B, not rap2A, appeared to be the major rap2 protein 
in human neutrophils. The identification and subcellular localization of rap 1 and rap2 proteins at the membranes ofgelatinase-rich granules uggest 
that these proteins could play a role in the regulation of the rapid and selective mobilization of gelatinase-containing granules in human neutrophils. 
Rapl protein; Rap2 protein; Gelatinase-rich granule; Human neutrophil 
1. INTRODUCTION 
Four distinct granule populations have been reported 
in human neutrophils, namely: azurophilic granules, 
specific granules, gelatinase-rich tertiary granules and 
alkaline phosphatase-rich granules or phosphasomes 
[1 7]. Recent evidence suggests that gelatinase-contain- 
ing granules could be a subpopulation of the previously 
described specific granules [5,8,9]. However, the exis- 
tence of separate gelatinase-rich tertiary granules is con- 
firmed by a different distribution pattern in subcellular 
fractionation studies as well as by a differential and 
prone release of gelatinase marker as compared to other 
granule markers, including those of specific granules 
[3,4,5,9 12]. Fusion of the different granule populations 
with the plasma membrane may occur independently. 
Thus, mobilization of gelatinase-containing granules 
can be induced readily under conditions which mobilize 
slightly the specific granules and hardly mobilize the 
azurophilic granules [10-12]. As the gelatinase-rich 
granules contain proteins involved in cell adhesion 
processes [5,13,14] as well as in diapedesis [3 5,9], it has 
been postulated that the rapid mobilization of these 
granules can modulate arly neutrophil responses upon 
cell activation [5]. Degranulation of neutrophils must 
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implicate specific recognition of the plasma membrane 
fusion site by the granules, bringing membranes into 
close contact, and subsequent fusion of membranes. 
The differential degranulation may likely involve the 
presence of different proteins in the surface of the dis- 
tinct granule populations, which can regulate the selec- 
tive mobilization of neutrophil granules. GTP ana- 
logues can induce secretion in human neutrophils 
[15,16], suggesting that GTP-binding proteins are in- 
volved in exocytosis in human neutrophils. A distinct 
pattern of low molecular mass GTP-binding proteins 
has been described in the different granule populations 
[17,18]. More recently, rapl and rap2 proteins have 
been reported to be located both at the surface of the 
specific granules and in the plasma membrane [19]. Fur- 
thermore, rap lA has also been found colocalized with 
cytochrome b in plasma membrane and specific gran- 
ules in human neutrophils [20], and evidence indicates 
a functional association of these two molecules in intact 
neutrophils, suggesting that raplA is required for as- 
sembly of a functional superoxide-generating system 
[21,22]. 
ras-related genes constitute a group of genes encoding 
a series of proteins that share between 30 to 85% homol- 
ogy with ras proteins [23]. Among the ras superfamily 
of small GTP-binding proteins, the rap proteins com- 
prise four members: raplA, raplB, rap2A and rap2B 
[23-25]. While rapl proteins are 70% identical to rap2 
proteins, raplA is 95% identical with raplB [24], and 
rap 2A is 90% identical with rap2B [25]. 
Using specific antibodies to rapl and rap2 proteins, 
we herein report hat rapl protein is located both in the 
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p lasma membrane  and in the membranes  of  gelatinase- 
conta in ing  granules,  and  that rap2 prote in is main ly  
located in ge lat inase-conta in ing granule  membranes  
with a minor  locat ion in fract ions enr iched in p lasma 
membrane .  This rap2 protein seems to cor respond pre- 
dominant ly  to the rap2B prote in as we report  here that 
rap2A is undetectable in human neutrophi ls .  
2. MATERIALS  AND METHODS 
2.1. Cell isolation and subcellular fractionation 
Neutrophils were obtained from fresh human peripheral blood by 
dextran sedimentation a d centrifugation on Ficoll-Hypaque, fol- 
lowed by hypotonic lysis of residual erythrocytes as previously de- 
scribed [26]. The final cell preparation contained more than 98% 
neutrophils, as assessed by Giemsa Wright stain. 
Neutrophils (about 700 x 106) were disrupted by hypotonic shock 
and homogenization in a PottemElvehjem tissue grinder in the pres- 
ence of 2 mM PMSF as described [9,27]. The postnuclear supernatant 
(6 ml) was layered onto a 27 ml, 15-40% (w/w) continuous sucrose 
gradient, with a 1 ml cushion of 60% (w/w) sucrose, and centrifuged 
in a SW-27 rotor at 25,000 rpm (113,000 × g,na0 for 15 min at 4°C as 
previously described [9,27]. At the end of the run, fractions (the first 
one of 6 ml, containing the cytosol, and the remaining seven of 4 ml 
each) were collected by pumping 60% (w/w) sucrose into the bottom. 
Fractions were stored at -20°C in the presence of 2 mM PMSF. 
Membranes from each fraction were obtained by dilution of the frac- 
tions with 50 mM Tris-HC1, pH 8.0, 100 mM NaCI, and centrifugation 
in a 30-type rotor at 29,000 rpm (99,000 xgm~x) for 90 min at 4°C as 
previously described [9]. Membranes were resuspended in 50 mM 
Tris-HC1, pH 7.6 containing 2 mM PMSF. 
The marker enzymes lactate dehydrogenase, 5'-nucleotidase, g lati- 
nase, lysozyme and peroxidase were assayed as described [4,11]. Alka- 
line phosphatase was assayed as described [11], in the presence of 1% 
Triton X-100 to avoid underestimation of latent activity. Lactoferrin 
was assayed as described [4]. Protein determination was carried out 
by the Bradford method [28], using BSA as standard. 
2.2. Generation of recombinant rap proteins 
The four known human rap genes (1A, 1B, 2A and 2B) were cloned 
by PCR techniques from total RNA from either human platelets, 
Jurkat or K562 cells. Independent PCR reactions were performed for 
each gene in a PHC-2 Techne thermocycler (Cambridge, UK) accord- 
ing to the manufacturer's indications, and using the following primers: 
raplA 
(forward) 5'GAC GAATTCATGC GTGAT TACAAG 3" 
(backward) 5 'GACGAATTCGGCCTAGAGCAGCAG 3' 
raplB 
(forward) 5 'CAGCGAATTCATGCGTGAGTATAA 3' 
(backward) 5"CAGCGAATTCGTATTAAAGCAGCT 3' 
rap2A 
(forward) 5 'CAGGGAATTCATGCGCGAGTACAA 3' 
(backward) 5"CAGGAATTCGTATTGTATGTTACATG 3' 
rap2B 
(forward) 5'GAGGAATTCACGGAGC CATGAGA 3' 
(backward) 5 'GAGGAATTCCCTCAGTAGGATCAC 3' 
The above primers inserted an EcoRI restriction site at both ends 
of the complete coding sequence of each rap gene. This strategy al- 
lowed to subclone the genes into the bacterial expression vector 
pRC23 as previously described [29]. High level expression colonies 
were then selected and the respective proteins were purified following 
a procedure previously reported [29]. 
2.3. Generation of antisera gainst rap proteins 
Sera were generated in rabbits by injection of either the full length, 
purified recombinant rap2B protein, or the synthetic peptides corre- 
sponding to residues 127 144 or rapl (NH2-GKEQGQN- 
LARQWCNCAFL-COOH) and to residues 164~183 ofrap2A (NH 2- 
MNYAAQPDKDDPCCSACNIQ-COOH) conjugated to BSA with 
glutaraldehyde as previously described [30]. 
2.4. Immunoblot analysis 
Proteins were separated through 12% or 15% SDS-polyacrylamide 
gels under reducing conditions, transferred to nitrocellulose filters, 
and subjected to immunological detection basically as described [31]. 
Low range pre-stained protein molecular mass standards (Bio-Rad, 
Richmond, CA, USA) were also run in the same gel. After electroblot- 
ting and blocking for 1 h in 2% powdered efatted milk in TBS buffer 
(50 mM Tris-HCl, pH 8.0, 150 mM NaCI), the nitrocellulose filters 
were incubated overnight with the respective specific anti-rap antibod- 
ies at a dilution of 1:500 in TBS buffer containing 0.05% Tween 20. 
Signal was developed either using a goat anti-rabbit immunoglobulin 
coupled to alkaline phosphatase according to standard techniques [31] 
or by incubation with [~25I]protein A (0.5 ¢tCi/ml) and autoradiogra- 
phy at -80°C. In order to achieve an enhanced visualization of the 
corresponding band, signal was also developed using a biotin-strep- 
tavidin system (Amersham, Buckinghamshire, UK) according to the 
manufacturer's in tructions, and using 1.7 mM 3,3"-diaminobenzidine 
with 0.03% (v/v) H202 in 50 mM Tris-HCl, pH 7.4, as a substrate 
solution. 
3. RESULTS AND DISCUSSION 
3.1. Specificity of anti-rapl, anti-rap2 and anti-rap2A 
antibodies 
We raised a polyc lonal  ant i serum directed against  a 
peptidic sequence un ique to rap l ,  cor respond ing  to res- 
idues 127-144 of  rap lA .  This sequence is 94% identical 
to that o f rap lB .  The polyc lonal  ant i serum against  rap2 
was raised f rom a purif ied preparat ion  of  the recombi-  
nant  rap2B prote in expressed in Escherichia coli. The 
ant i - rap2A ant iserum was directed against  a peptidic 
sequence un ique  to rap2A protein,  cor responding to 
residues 164-183 of  rap2A,  which shows a 20% identity 
to that of rap lA  and  a 65% identity to that of  rap2B. 
The specificity o f  these ant isera was assessed with the 
dist inct purif ied recombinant  rap lA ,  rap lB ,  rap2A and  
rap2B proteins (Fig. 1). Ant ibod ies  against  rap l only 
recognized rap l A and  rap l B, but  not  rap2A and  rap2B 
proteins (Fig. 1A). Likewise, ant ibodies against  rap2 
only recognized rap2A and rap2B, but  not  rap lA  and 
rap l B proteins (Fig. 1A). The ant i serum against  rap2A 
was highly specific and  dit not  cross-react with rap2B, 
rap lA  or rap lB  proteins (Fig. 1A). In fact, cross-reac- 
t ion of  the ant i - rap2A ant ibodies with rap2B resulted 
a lmost  negligible when the ant iserum was used at a 
d i lut ion of  1:500 (Fig. 1B). D i lut ions  of  the ant i - rap2A 
ant i serum at 1:200 gave identical results (data not  
shown). None  of  the ant ibodies used cross-reacted with 
ras or rho proteins under  similar condi t ions  (data not  
shown), indicat ing their specificity to rap proteins.  
3.2. Subcellular distribution of rapl, rap2 and rap2A 
proteins in resting neutrophils 
Postnuc lear  fract ions prepared f rom resting human 
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Fig. 1. Characterization fthe specificity of the antibodies directed against rap1, rap2 and rap2A proteins by immunoblotting. (A) The purified 
recombinant rap2A (lane 1), rap2B (lane 2), raplA (lane 3) and raplB (lane 4) proteins were run on 12% SDS-polyacrylamide gels (30 ng/lane) 
and transferred to nitrocellulose filters which were incubated with anti-rapl, anti-rap2 or anti-rap2A antibodies as described in section 2. (B) 
Different amounts of purified recombinant rap2B and rap2A proteins were run on a 12% SDS-polyacrylamide gel, processed asabove and incubated 
with anti-rap2A antibody. Bands were visualized using [~2SI]protein A. Arrowheads indicate the positions of the respective rap proteins. 
neutrophils were centrifuged in the presence of 2 mM 
PMSF to obtain soluble, containing cytosol, and mem- 
brane fractions. We found that rapl and rap2 proteins 
were located in the membrane fraction, as determined 
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Fig. 2. Immunoblot analysis of rapl and rap2 proteins in cytosolic and 
membrane fractions from resting human neutrophils. Postnuclear 
fractions from resting human neutrophils, prepared as described in 
section 2, were centrifuged in the presence of 2 mM PMSF at 
99,000 xgmax for 90 min at 4°C, and the cytosolic and membrane 
fractions collected. Equal amounts of cytosolic (lane 1) and membrane 
(lane 2) proteins (40/zg/lane) were run on 15% SDS-polyacrylamide 
gels and analyzed by immunoblotting using specific anti-rapl (A) and 
anti-rap2 (B) antibodies, and [~251]protein A for signal development. 
Arrowheads indicate the positions of the respective rap proteins. The 
molecular masses (kDa) of protein markers are shown on the left. 
by immunoblott ing with specific antisera (Fig. 2). Nei- 
ther rapl nor rap2 proteins were detected in neutrophil 
cytosol (Fig. 2). In order to further examine the subcel- 
lular localization o f rap l  and rap2 proteins, postnuclear 
fractions obtained from resting neutrophils were sepa- 
rated by rate zonal centrifugation on a continuous u- 
crose gradient under conditions that resolved cytosol 
(lactate dehydrogenase), plasma membrane (5'-nucleo- 
tidase), gelatinase-rich tertiary granules (gelatinase), 
specific granules (lysozyme and lactoferrin), and azuro- 
philic granules (peroxidase) as shown in Fig. 3A. Alka- 
line phosphatase has been localized in a novel light 
density organelle named phosphasome [6,7]. Neverthe- 
less, we found that alkaline phosphatase, measured in 
the presence of  Triton X-100 to take into account the 
latent pool of  this enzyme activity [7], cofractionated 
with the plasma membrane marker 5"-nucleotidase. 
Thus, under the fractionation conditions used, we were 
unable to separate plasma membrane from the alkaline 
phosphatase-rich organelle. Gelatinase-rich tertiary 
granules (fractions 4 and 5) were resolved from specific 
granules (fractions 5 and 6), as well as from azurophilic 
granules (fraction 8) and the plasma membrane (frac- 
tions 2 and 3). Furthermore, we found by immunoblot 
analysis, using a specific antigelatinase antibody (kindly 
provided by M. Nakaj ima and A. Fabra), that the 92 
kDa gelatinase was located mainly in fractions 4 and 5 
(data not shown). 
To analyze the subcellular localization of  rap pro- 
teins, we prepared membranes from the distinct subcel- 
lular fractions obtained in Fig. 3A and performed im- 
munoblots with the respective antibodies. As shown in 
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~lg..3. Subcellular localization of rapl and rap2 proteins in resting human neutrophils. (A) Subcellular distributions of marker enzymes after 
gradient centrifugation of postnuclear f actions obtained from resting human neutrophils as described in section 2. Plots of percent of total activity 
in each fraction (versus volume) are shown. The total amounts of protein, lactoferrin as well as the total enzyme activities for each marker enzyme 
in all the fractions are taken as 100%. The actual activity values for the distinct enzyme markers in the postnuclear f action of resting human 
neutrophils have been previously reported [27]. Values are shown as mean _+ S.E. of three independent determinations. The percentages of recovered 
activities were higher than 80% for all the assayed markers. (B) Equal amounts of membrane proteins (30 #g/lane), prepared from the postnuclear 
fraction as well as from the subcellular f actions of resting human neutrophils shown in (A) were run on l 5% SDS-polyacrylamide g ls and analyzed 
by immunoblotting using specific anti-rapl and anti-rap2 antibodies as described in section 2. Bands were visualized using an anti-rabbit 
immunoglobulin coupled to alkaline phosphatase. Lane 1, molecular mass protein markers; lane 2, membranes from postnuclear extract (E); lanes 
3 9, membranes i olated from the subcellular fractions 2-8 shown in A. The positions of rapl and rap2 proteins are indicated with arrowheads. 
The molecular masses (kDa) of protein markers are indicated on the left. 
Fig. 3B, the rapl protein was mainly localized in frac- 
tions enriched in plasma membrane and gelatinase-rich 
tertiary granules. The rap2 protein was predominantly 
located in gelatinase-rich tertiary granules, and a lower 
amount of rap2 protein was detected in fractions en- 
riched in plasma membrane (Fig. 3B). However, no 
rap l or rap2 proteins were found in azurophilic gran- 
ules (Fig. 3B). Although the specific and gelatinase-rich 
tertiary granules partially overlapped under the frac- 
tionation conditions used [4,9], the intracellular localiz- 
ation of both rapl and rap2 proteins correlated better 
with the distribution pattern of gelatinase-rich granules 
than with the distribution pattern of specific granules 
(Fig. 3). Thus, the present data indicate that both rapl 
and rap2 proteins are localized in fractions enriched in 
plasma membrane and in the membranes of gelatinase- 
rich granules in resting human neutrophils. Rap2 pro- 
tein is mainly located at the gelatinase-rich granules, 
whereas rap 1 protein is more evenly distributed between 
these organelles and the plasma membrane. 
As the anti-rap2 antibody was not able to discrimi- 
nate between rap2A and rap2B proteins, we analyzed 
the presence of rap2A protein in the subcellular frac- 
tions using a highly specific anti-rap2A antibody (Fig. 
1). We were unable to detect a specific signal for rap2A 
in the membranes of the distinct neutrophil subcellular 
fractions using three different methods to visualize the 
specific rap2A band, namely incubation with ['25I]pro- 
tein A, with goat anti-rabbit immunoglobulin coupled 
to alkaline phosphatase or with a biotin-streptavidin 
system (Fig. 4). These results indicate that the major 
form of rap2 protein present in human neutrophils is 
rap2B, and that the anti-rap2 antibody used in the pres- 
ent study recognizes mainly rap2B protein in human 
neutrophils. Furthermore, the data herin reported indi- 
cate that rap2B protein is predominantly located in the 
212 
Volume 326, number 1,2,3 FEBS LETTERS July 1993 
I 2 3 4 5  6 7  8 9 
9.,.5 
2.5 - -~  
7". 5 --',~ ,,~ 
8.51  
anti-rap 2A 
Fig. 4. Subcellular localization of rap2A protein in resting human 
neutrophils. Equal amounts of membrane proteins (30 ,ug/lane), pre- 
pared from the postnuclear f action as well as from the subcellular 
fractions of resting neutrophils shown in Fig. 3A, were run on a 15% 
SDS-polyacrylamide g l and analyzed by immunoblotting using a 
specific anti-rap2A antibody and a biotin-streptavidin system for sig- 
nal development. Lane 1, molecular mass protein markers; lane 2, 50 
ng of purified recombinant rap2A; lane 3, membranes from postnu- 
clear fraction; lane 4, cytosol (fraction 1, Fig. 3A); lanes 5-9, mem- 
branes isolated from the subcellular fractions 2-6 shown in Fig. 3A. 
The position of rap2A protein is indicated with an arrowhead. The 
molecular masses (kDa) of protein markers are indicated on the left. 
membranes of gelatinase-rich granules. The polyclonal 
anti-rapl antibody used in the present study could not 
discriminate between rap lA and rap l B proteins. How- 
ever, it has been recently shown that the human neutro- 
phil rapl protein is fundamentally, if not exclusively, 
raplA [32]. Taken together these data, we suggest hat 
the readily mobilized gelatinase-rich granules contain at 
their membranes both the rap2B and raplA proteins. 
By quantitative Western blot analysis using specific an- 
tibodies and purified recombinant raplA and rap2B 
proteins as standards, we estimate that raplA and 
rap2B proteins are present in the membranes of the 
gelatinase-rich granules at a level of 1.8 + 0.3 and 
5.6 + 0.5 ¢tg/mg of membrane protein (n = 3), respec- 
tively (Fig. 5). Fractions enriched in plasma membrane 
contained a slightly higher amount of raplA protein 
(2.3 + 0.4 /lg/mg of membrane protein) and a lower 
level of rap2B protein (0.9 + 0.2 ¢tg/mg of membrane 
protein). Interestingly, we found that the rap2 protein 
was often detected as a doublet in immunoblots (Fig. 
5B). This doublet has been previously detected in rest- 
ing platelets [33] and in phorbol ester-stimulated neutro- 
phils [19]. 
Neither rapl nor rap2 proteins were detected in the 
cytosol or in the azurophilic granules, which are slug- 
gishly mobilized in human neutrophils. As we found a 
partial overlapping between gelatinase-rich granules 
and specific granules under the subcellular f actionation 
conditions employed, we cannot rule out that some of 
the rap l and rap2 proteins are also located in the spe- 
cific granule population. Nevertheless, the distribution 
pattern of rap2 and rap 1 proteins correlated better with 
the marker for gelatinase-containing or anelles than 
with the markers for specific granules. A recent report 
has shown the localization of rapl and rap2 proteins in 
both plasma membrane and specific granules [19]. How- 
ever, gelatinase activity was not measured in that study, 
and specific and gelatinase-rich tertiary granules have 
almost identical densities, being difficult o resolve from 
each other except under certain fractionation conditions 
where sedimentation velocity is used [3,4,9]. We could 
not resolve plasma membrane from the alkaline phos- 
phatase-rich organelle. Thus, it might also be suggested 
that a portion of the rapl and rap2 proteins found in 
the plasma membrane fraction corresponds to the alka- 
line phosphatase-rich organelle. In this context, the al- 
kaline phosphatase-rich and the gelatinase-rich organ- 
elles have been reported to be prone to fuse with the 
plasma membrane upon gentle stimulation and to pre- 
cede fusion of specific and azurophilic granules [3,5,7,9 
12]. Thus, we could envisage that the presence of rap 1A 
and rap2B in neutrophil ntracellular granules is corre- 
lated with their readiness to be mobilized. 
The presence of raplA and rap2B in gelatinase-rich 
granules uggests that these proteins may be involved 
in the regulation of the rapid and selective mobilization 
of these organelles upon neutrophil activation, which 
seems to be of pivotal importance in neutrophil adhe- 
sion, diapedesis and migration into the inflammatory 
sites. 
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Fig. 5. Quantitative Western blot analysis of raplA and rap2B pro- 
teins. Membrane proteins (40/lg/lane) from the gelatinase-rich gran- 
ules (fractions 4 and 5, Fig. 3A) were run on 15% SDS-polyacrylamide 
gels and analyzed by immunoblotting using specific anti-rapl and 
anti-rap2 antibodies, and [~25I]protein A for signal development. In the 
same gel, distinct amounts of purified recombinant raplA and rap2B 
proteins were also run and processed as above. The relative amounts 
of rap proteins in each subcellular f action were determined by cutting 
out  the immunoreactive r gions of the nitrocellulose filters and count- 
ing in a gamma counter. Arrowheads indicate the positions of rap l 
and rap2 proteins. The molecular masses (kDa) of protein markers are 
shown on the left. 
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